Latest study by John Ioannidis (world-renowned scientist) - COVID Infection Fatality Rate (IFR) by age
👍︎ 28
💬︎
📅︎ Jan 17 2022
🚨︎ report
John Ioannidis - Where are we now with COVID19? youtube.com/watch?v=YvEOw…
👍︎ 4
💬︎
👤︎ u/peetss
📅︎ Dec 31 2021
🚨︎ report
John Ioannidis - Where are we now with COVID19? youtu.be/YvEOwKUyur0
👍︎ 32
💬︎
📅︎ Dec 09 2021
🚨︎ report
Top epidemiologist Professor John Ioannidis has published a new study which concludes that the survival rate of people under the age of 20 who catch COVID is 99.9987%. mobile.twitter.com/Prison…
👍︎ 2
💬︎
👤︎ u/Bonus1Fact
📅︎ Jan 11 2022
🚨︎ report
John Ioannidis: over-and under-estimation of COVID-19 deaths link.springer.com/content…
👍︎ 109
💬︎
👤︎ u/lanqian
📅︎ Aug 02 2021
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic" youtu.be/B_ehqHQOBO0
👍︎ 74
💬︎
👤︎ u/ElDanio123
📅︎ Jun 28 2021
🚨︎ report
Is universal vaccination a no-brainer supported by science? Far from it, as explained by renowned epidemiologist John Ioannidis, Professor of Medicine (Stanford Prevention Research), of Epidemiology and Population Health and by courtesy, of Statistics and of Biomedical Data Science at Stanford Univ.

John Ioannidis also famously demonstrated that a large proportion of published research findings are false.

https://en.wikipedia.org/wiki/Why_Most_Published_Research_Findings_Are_False

https://onlinelibrary.wiley.com/doi/full/10.1111/eci.13678

>8 SOCIODEMOGRAPHIC FEATURES AND RISK STRATIFICATION
>
>Besides age—that has a major impact of risk stratification both for COVID-19 risks that can be averted from vaccination and for some of the known adverse events of vaccination—other clinical and socioeconomic factors may also markedly affect risk-benefit ratios. Most COVID-19 hospitalizations and deaths occur in people with major comorbidities25; this applies also to young age strata. For children and young adults without comorbidities, risk of severe COVID-19 disease outcomes is likely far lower than the overall risk in these age groups. Moreover, COVID-19 is a disease of inequality, with worse COVID-19-related health care (eg, access to testing), and much higher burden of disease and severe outcomes in disadvantaged populations, lower socioeconomic strata and specific racial groups. However, the paediatric literature on these inequalities is sparse26-28 compared with studies in adults and elderly people. Detailed granular information on the sociodemographic profile of COVID-19 severe disease and deaths in children and young adults needs to be collected and analysed across different countries with varying profiles for social determinants of disease. Such evidence may afford better risk stratification to rationally design vaccination and/or other intervention strategies targeted specifically towards subsets of high-risk individuals and settings—concurrently perhaps sparing unnecessary interventions among those at negligible risk.

---

Sick of the feigned erudition of the plebeian filth at r/singapore and everywhere else mindlessly parroting their woefully misguided imagination that universal vaccination is overwhelmingly supported by science.

Emboldened by their groupthink and the tired narrative pushed by the state-sanctioned mainstream media propaganda machi

... keep reading on reddit ➡

👍︎ 5
💬︎
📅︎ Oct 11 2021
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic

https://www.youtube.com/watch?v=B_ehqHQOBO0

>Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic"

> Hosted by Univ.-Prof. Dr. Manuel Schabus, University of Salzburg > > -- > > I have the pleasure to invite you to a talk of Prof. Dr. John P.A. Ioannidis (for biography see here: (https://profiles.stanford.edu/john-ioannidis) on the 26th of June 2021 (10am). John is Professor of Medicine, Epidemiology and Population Health, and (by courtesy) of Biomedical Data Science, Statistics, and Co-Director of the Meta-Research Innovation Center at the University of Stanford (METRICS). USA. Prof. Ioannidis is one of the 10 currently most cited scientists across all disciplines (current citation rate above 6000 per month) and has a h-index of 213. He published extensively on the COVID-19 pandemic and is hosted by Prof. Manuel Schabus of the doctoral college IM & Centre for Cognitive Neuroscience (CCNS). > > -- > > > Abstract: > > COVID-19 has been a major crisis worldwide with severe repercussions from the pandemic itself, the impact on health systems (especially for vulnerable countries) as well as the measures taken to handle the pandemic. This has resulted in an unnecessary surplus of excess deaths with severe damage on all aspects of health (including mental health) and societal well-being. The lecture of Prof. Ioannidis will focus on what we have learned about the epidemiology of COVID-19, with emphasis on its extreme risk stratification, the debates about the infection fatality rate and the extent of population spread of the infection, the need to protect vulnerable populations and settings, and the poor evidence base for most of the horizontal measures taken. The lecture will also evaluate the current status and prospects of ending the pandemic and entering an endemic phase, given the widespread distribution of the virus and the advent of effective vaccines.

👍︎ 38
💬︎
📅︎ Jun 30 2021
🚨︎ report
Prof. John Ioannidis: “There was a clash between two schools of thought, authoritarian public health versus science—and science lost.” tabletmag.com/sections/sc…
👍︎ 42
💬︎
📅︎ Sep 09 2021
🚨︎ report
John Ioannidis "COVID-19 epidemiology: risks, measures, and ending the pandemic" edited version youtu.be/e4grP1718Ps
👍︎ 35
💬︎
👤︎ u/SirKeplan
📅︎ Jul 02 2021
🚨︎ report
Prof. John Ioannidis: “There was a clash between two schools of thought, authoritarian public health versus science—and science lost.” tabletmag.com/sections/sc…
👍︎ 2
💬︎
📅︎ Sep 10 2021
🚨︎ report
WHO publishes John Ioannidis paper estimating IFR who.int/bulletin/online_f…
👍︎ 211
💬︎
📅︎ Oct 14 2020
🚨︎ report
Stanford Epidemiologist John Ioannidis: For people younger than 45, the infection fatality rate is almost 0% washingtonexaminer.com/ne…
👍︎ 421
💬︎
👤︎ u/SoundSalad
📅︎ Jul 02 2020
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic" youtube.com/watch?v=e4grP…
👍︎ 4
💬︎
📅︎ Jun 30 2021
🚨︎ report
Épidémiologie du Covid-19 ; conférence du professeur John Ioannidis de Stanford. youtu.be/8KzZXvT1g-k
👍︎ 11
💬︎
📅︎ Feb 24 2021
🚨︎ report
"Effects of non-pharmaceutical interventions on COVID-19: A Tale of Two Models": new preprint by John Ioannidis, among others, regarding the Imperial College modeling medrxiv.org/content/10.11…
👍︎ 75
💬︎
👤︎ u/KuduIO
📅︎ Jul 28 2020
🚨︎ report
EXCELLENT Presentation by Professor John Ioannidis - Covid Reality Revealed! [32:50] youtube.com/watch?v=e4grP…
👍︎ 3
💬︎
👤︎ u/DMHshadow
📅︎ Jun 30 2021
🚨︎ report
What the heck happened to John Ioannidis? sciencebasedmedicine.org/…
👍︎ 30
💬︎
👤︎ u/mingy
📅︎ Mar 31 2021
🚨︎ report
New study from John Ioannidis et al.: “Assessing Mandatory Stay‐at‐Home and Business Closure Effects on the Spread of COVID‐19” onlinelibrary.wiley.com/d…
👍︎ 42
💬︎
📅︎ Jan 10 2021
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic" youtube.com/watch?v=B_ehq…
👍︎ 3
💬︎
📅︎ Jun 30 2021
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic" youtu.be/B_ehqHQOBO0
👍︎ 2
💬︎
📅︎ Jun 30 2021
🚨︎ report
Most biomedical/nutrition research is flawed -- a discussion between Peter Attia and John Ioannidis

Dr. Iaonnidis studies the research space at the meta level evaluating the rigor of studies. This is very important because most of the recommendations that spring up in the nutrition space including this sub lean on findings from said research on nutrition.

https://youtu.be/gzLANQ7xkD8

👍︎ 12
💬︎
👤︎ u/SilverRule
📅︎ Jan 05 2021
🚨︎ report
Dr. John Ioannidis On CNN twitter.com/cnn/status/12…
👍︎ 142
💬︎
👤︎ u/FudFomo
📅︎ May 03 2020
🚨︎ report
New pre-print from John Ioannidis: Median fatality rate for those under age 70 is just 0.04% medrxiv.org/content/10.11…
👍︎ 169
💬︎
📅︎ Jun 19 2020
🚨︎ report
A Conversation with John Ioannidis thehealthcareblog.com/blo…
👍︎ 54
💬︎
📅︎ Jul 09 2020
🚨︎ report
Professor John Ioannidis - Covid Reality youtube.com/watch?v=e4grP…
👍︎ 2
💬︎
📅︎ Jun 29 2021
🚨︎ report
John Ioannidis - latest research suggests lockdowns not helpful in reducing covid

From The Australian newspaper, published May 10 2021:

One of the world’s top scientists has questioned the benefits of lockdowns, suggesting shutting the international border — and a lack of COVID-19 in the first place — were better explanations for Australia’s success than mandatory social distancing.

Stanford University professor John Ioannidis, among the world’s top epidemiologists, also said he couldn’t rule out SARS-Cov2 ­having escaped from the Chinese virology lab in Wuhan, where the virus first emerged.

“My default position is it arose naturally but it is possible some sort of an accident occurred in the lab or that researchers were in­fected while collecting samples from natural habitats,” he told The Australian.

His comments come soon after a third lockdown in Perth and confirmation by Scott Morrison that Australia’s border will remain shut “indefinitely” as the nation pursues what has become a highly popular “zero COVID” strategy.

Professor Ioannidis, whose 2005 research paper Why Most Published Research Findings are False is among the most-read academic articles in history, also urged Australia to “push for vaccination very fast (given) you have very few people infected”.

“Otherwise I don’t see another way out. You will get your wave sooner or later,” he added.

Just over 10 per cent of the population has received at least one COVID-19 vaccination shot, compared to 45 per cent in the US, more than 50 per cent in the UK and over 60 per cent in Israel.

“What’s common to Australia and New Zealand and Taiwan, for instance, isn’t lockdowns but probably a much lower seeding of the virus to begin with, and the ability to close international borders easily and promptly,” he said.

“Almost all the countries that did lockdown did very badly. Lockdown is not the common theme for the success stories.”

His latest research with Sydney University statistician Sally Cripps, looking at 11 European countries, found lockdowns had “little or no benefit” as they were typically introduced after the “r rate”, or the reproduction number, had already started declining.

Professor Cripps told The Australian that lockdowns were like a “sledgehammer” and, if they had been appropriate early in 2020, they were not a few months later.

“From then on we knew the age profile of this thing. All we had to do in Victoria was shut down all nursing homes and be very careful around other people, and we could have avoided the 800 death

... keep reading on reddit ➡

👍︎ 3
💬︎
📅︎ May 10 2021
🚨︎ report
A fiasco in the making: More data is not the answer to the coronavirus pandemic. A response to John Ioannidis's article "A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data" researchers.one/article/2…
👍︎ 213
💬︎
📅︎ Mar 20 2020
🚨︎ report
John Ioannidis: Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic (Oct 7, 2020) onlinelibrary.wiley.com/d…
👍︎ 23
💬︎
📅︎ Oct 11 2020
🚨︎ report
Should governments continue lockdown to slow the spread of covid-19? - John Ioannidis vs. Edward Melnick bmj.com/content/369/bmj.m…
👍︎ 89
💬︎
📅︎ Jul 25 2020
🚨︎ report
John Ioannidis - Modelling by the Imperial College youtube.com/watch?v=rXulj…
👍︎ 57
💬︎
📅︎ Nov 09 2020
🚨︎ report
John P.A. Ioannidis: Scientific petitions and open letters in the covid-19 era - The BMJ blogs.bmj.com/bmj/2020/10…
👍︎ 47
💬︎
👤︎ u/Machuka420
📅︎ Oct 13 2020
🚨︎ report
What the heck happened to John Ioannidis? [Science-Based Medicine] sciencebasedmedicine.org/…
👍︎ 22
💬︎
📅︎ Mar 29 2021
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic

https://www.youtube.com/watch?v=B_ehqHQOBO0

>Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic"

> Hosted by Univ.-Prof. Dr. Manuel Schabus, University of Salzburg > > -- > > I have the pleasure to invite you to a talk of Prof. Dr. John P.A. Ioannidis (for biography see here: (https://profiles.stanford.edu/john-ioannidis) on the 26th of June 2021 (10am). John is Professor of Medicine, Epidemiology and Population Health, and (by courtesy) of Biomedical Data Science, Statistics, and Co-Director of the Meta-Research Innovation Center at the University of Stanford (METRICS). USA. Prof. Ioannidis is one of the 10 currently most cited scientists across all disciplines (current citation rate above 6000 per month) and has a h-index of 213. He published extensively on the COVID-19 pandemic and is hosted by Prof. Manuel Schabus of the doctoral college IM & Centre for Cognitive Neuroscience (CCNS). > > -- > > > Abstract: > > COVID-19 has been a major crisis worldwide with severe repercussions from the pandemic itself, the impact on health systems (especially for vulnerable countries) as well as the measures taken to handle the pandemic. This has resulted in an unnecessary surplus of excess deaths with severe damage on all aspects of health (including mental health) and societal well-being. The lecture of Prof. Ioannidis will focus on what we have learned about the epidemiology of COVID-19, with emphasis on its extreme risk stratification, the debates about the infection fatality rate and the extent of population spread of the infection, the need to protect vulnerable populations and settings, and the poor evidence base for most of the horizontal measures taken. The lecture will also evaluate the current status and prospects of ending the pandemic and entering an endemic phase, given the widespread distribution of the virus and the advent of effective vaccines.

👍︎ 8
💬︎
📅︎ Jun 30 2021
🚨︎ report
Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic

https://www.youtube.com/watch?v=B_ehqHQOBO0

>Prof. John P.A. Ioannidis talk on "COVID-19 epidemiology: risks, measures, and ending the pandemic"

> Hosted by Univ.-Prof. Dr. Manuel Schabus, University of Salzburg > > -- > > I have the pleasure to invite you to a talk of Prof. Dr. John P.A. Ioannidis (for biography see here: (https://profiles.stanford.edu/john-ioannidis) on the 26th of June 2021 (10am). John is Professor of Medicine, Epidemiology and Population Health, and (by courtesy) of Biomedical Data Science, Statistics, and Co-Director of the Meta-Research Innovation Center at the University of Stanford (METRICS). USA. Prof. Ioannidis is one of the 10 currently most cited scientists across all disciplines (current citation rate above 6000 per month) and has a h-index of 213. He published extensively on the COVID-19 pandemic and is hosted by Prof. Manuel Schabus of the doctoral college IM & Centre for Cognitive Neuroscience (CCNS). > > -- > > > Abstract: > > COVID-19 has been a major crisis worldwide with severe repercussions from the pandemic itself, the impact on health systems (especially for vulnerable countries) as well as the measures taken to handle the pandemic. This has resulted in an unnecessary surplus of excess deaths with severe damage on all aspects of health (including mental health) and societal well-being. The lecture of Prof. Ioannidis will focus on what we have learned about the epidemiology of COVID-19, with emphasis on its extreme risk stratification, the debates about the infection fatality rate and the extent of population spread of the infection, the need to protect vulnerable populations and settings, and the poor evidence base for most of the horizontal measures taken. The lecture will also evaluate the current status and prospects of ending the pandemic and entering an endemic phase, given the widespread distribution of the virus and the advent of effective vaccines.

👍︎ 3
💬︎
📅︎ Jun 30 2021
🚨︎ report

Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.